Status: current, Defined. Date: 31-Dec 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 463781011000036114 | efavirenz 600 mg + emtricitabine 200 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 463782011000036115 | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Is a | tenofovir + emtricitabine + efavirenz | false | Inferred relationship | Some | ||
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 1593100698 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has Australian BoSS | emtricitabine | true | Inferred relationship | Some | 1593100698 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has intended active ingredient | efavirenz | true | Inferred relationship | Some | 2076413338 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has Australian BoSS | efavirenz | true | Inferred relationship | Some | 2076413338 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has intended active ingredient | tenofovir | false | Inferred relationship | Some | 1604798377 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has Australian BoSS | tenofovir disoproxil fumarate | false | Inferred relationship | Some | 1604798377 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 2076413339 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Is a | efavirenz 600 mg tablet | true | Inferred relationship | Some | ||
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Is a | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet | false | Inferred relationship | Some | ||
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Is a | tenofovir disoproxil + emtricitabine + efavirenz | true | Inferred relationship | Some | ||
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has intended active ingredient | tenofovir disoproxil | true | Inferred relationship | Some | 302180754 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | has Australian BoSS | tenofovir disoproxil fumarate | true | Inferred relationship | Some | 302180754 | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Is a | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Atripla tablet | Is a | True | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Inferred relationship | Some | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 | has MPUU | True | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR